85
60
Growth Score 85 in past quarter
-2 pts
Heat Score 60 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1291443
HaploPharma is a pharmaceutical firm offering genetic analysis services such as genome sequence analysis and develops diagnostic equipment.
- Otaki Yoshihiro: CEO
About the Company
HaploPharma Inc. is a Planning surveys, research and development, dissemination of pharmaceuticals, diagnostics, health foods, diagnostic equipment, medical devices, etc. focusing on the development of new health care services based on genetic information and on advanced pharmacogenomics. We are developing technologies to discover genetic
biomarkers for the prediction of individual drug response.
◆ Business for the general public ◎ Health support business based on the development and provision of health assessment kits, health foods, and health-related equipment ◎ Service provision business that combines health and IT.